2nd Quarter - Report

CROSSROADS STRATEGIES, LLC for BRISTOL-MYERS SQUIBB

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R.1, One Big Beautiful Bill Act, all bio-pharmaceutical related provisions.

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
BRITTANY JOHNSON HERNANDEZ —
CHERYL LYNN JAEGER —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
LUCIA PANZA —
JASON BENJAMIN VAN PELT —
STEPHEN THOMAS VOLJAVEC New Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (119th)

Taxation/Internal Revenue Code TAX

Issues related to tax reform; R&D tax credit; international taxation; Inflation Reduction Act of 2022 (P.L.117-169) implementation; H.R.1, One Big Beautiful Bill Act.

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
BRITTANY JOHNSON HERNANDEZ —
CHERYL LYNN JAEGER —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
LUCIA PANZA —
JASON BENJAMIN VAN PELT —
STEPHEN THOMAS VOLJAVEC New Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (119th)

Copyright/Patent/Trademark CPT

Biopharmaceutical innovation and patent policy issues. Bayh-Dole march-in rights policy issues.

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
BRITTANY JOHNSON HERNANDEZ —
CHERYL LYNN JAEGER —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
LUCIA PANZA —
JASON BENJAMIN VAN PELT —
STEPHEN THOMAS VOLJAVEC New Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Issues related to pharmaceutical IP, supply chain, and tariffs.

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
BRITTANY JOHNSON HERNANDEZ —
CHERYL LYNN JAEGER —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
LUCIA PANZA —
JASON BENJAMIN VAN PELT —
STEPHEN THOMAS VOLJAVEC New Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, and PBM reform; Inflation Reduction Act of 2022 (P.L.117-169) implementation; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
BRITTANY JOHNSON HERNANDEZ —
CHERYL LYNN JAEGER —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
LUCIA PANZA —
JASON BENJAMIN VAN PELT —
STEPHEN THOMAS VOLJAVEC New Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 891 (119th)

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Drug Pricing; Inflation Reduction Act of 2022 (P.L.117-169) implementation.

LobbyistCovered position, as disclosed
SALIM ALAMEDDIN —
BRITTANY JOHNSON HERNANDEZ —
CHERYL LYNN JAEGER —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
LUCIA PANZA —
JASON BENJAMIN VAN PELT —
STEPHEN THOMAS VOLJAVEC New Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.